Gene and Cell Therapy – News and Features

Researchers have developed a continuously replicating model of human lip cells from donated tissue, overcoming challenges in lip research. This new model allows for extended study of lip biology, aiding in the understanding of lip conditions.

A study found a gene in human cytomegalovirus (HCMV) that can block immune responses needed for an effective HIV vaccine. This discovery could improve future vaccine designs for HIV and other diseases.

This article highlights several inspiring men and women working across academia and industry who are breaking barriers and regaining ownership of their own narratives.

In an interview with Technology Networks, Dr. Frederic Cedrone, vice president of corporate innovation at Catalent, discussed the challenges faced and solutions found by companies developing iPSC-derived cell therapies.

We reached out to start-ups at ELRIG Drug Discovery 2024 to see how AI and bioengineering can be applied in biotech and drug discovery.

Technology Networks spoke to Dr. Dan Strange, CTO at Cellular Origins, to discuss how integrating proven tools and technologies, such as automation, helps cell therapy companies scale up production.

In this interview, Dr. Graeme Daniels, Sphere Fluidics, shares how advanced microfluidics are set to revolutionize biotherapeutic workflows and discusses the technology's future potential in broader applications, including cell and gene therapy.

Researchers developed an mRNA vaccine that protects against C. difficile infections. The vaccine induces a strong immune response, promotes bacterial clearance, and shows potential for broader applications.

Researchers have reproduced the developmental process of blood stem cells in vitro, enhancing our understanding of how these stem cells develop and offering insights into stem cell therapy.

Researchers developed a method to enhance mesenchymal stromal cells (MSCs) for cartilage tissue regeneration by adding ascorbic acid during cell expansion. This study also highlights micro magnetic resonance relaxometry (µMRR) as a novel tool.